Navigation Links
UCLA Program Aims to Revolutionize Kidney Transplants
Date:8/19/2007

LOS ANGELES, Aug. 10 /PRNewswire-USNewswire/ -- New and innovative programs to obtain donor organs have the potential to revolutionize kidney transplantation. At UCLA, for example, transplant experts are studying a program they call "living donor swap."

This program enables the relative or friend of a kidney-transplant patient who is not compatible as a donor to "swap" organs with another potential donor who also may be an incompatible match for his or her relative or friend. This greatly broadens the pool of organs available from living donors.

"Swapping organs makes sense in such cases," says Albin Gritsch, M.D., UCLA urologist.

In the case of a "living donor swap," both transplants are done simultaneously, Dr. Gritsch explains. Advances in living-donor-transplant technology make the surgery less invasive and the pain easier to manage.

UCLA has been among the pioneers in the field of kidney transplantation, and consistently ranks among the top five centers nationally. Currently, about two-thirds of kidney transplants are performed with organs taken from deceased donors, explains UCLA nephrologist Alan Wilkinson, M.D., and the wait can often be as long as five years, making living-donor transplantation an attractive alternative. Living donors, often family or friends of the transplant patient, currently account for about one third of cases.

The door to increasing living-donor transplantation also has been opened wider with pioneering surgical techniques, including laparoscopic harvesting of donor kidneys, which results in less pain and a quicker recovery, notes Gabriel Danovitch, M.D., director of Kidney and Kidney/Pancreas Transplantation at UCLA.

To view a video about an actual living donor kidney transplant, go to http://streaming.uclahealth.org/kidney.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE University of California, Los Angeles (UCLA), Health
Sciences

Copyright©2007 PR Newswire.

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
3. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
4. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
5. Pharmexa A/S (DK) - Pharmexa presents data from influenza program
6. Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
7. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
8. CuraGen Presents Update on Clinical Development Program for Belinostat
9. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
10. Diatos Announces Positive Clinical Results for its DTS-201 Doxorubicin Prodrug Program
11. OXiGENE Abstracts Published in ASCO Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/28/2017)... LONDON , March 28, 2017  "US ... insight on the various indicators and trend analysis ... generics drugs in mainstream pharmaceutical market in US. ... responsible for the growth on cancer generics drugs ... resulted in saving of billions of dollars for ...
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
Breaking Medicine Technology:
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a ... Personal Emergency Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are ... of their kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
Breaking Medicine News(10 mins):